Don't stop walking: the in-home rehabilitation program for peripheral artery disease patients during the COVID-19 pandemic.
Study Goal
The researchers aimed to determine whether a structured in-home walking program maintained mobility and improved outcomes in peripheral artery disease (PAD) patients during COVID-19 lockdowns.
Results Summary
The study found that the walking program was adhered to safely, with improved pain-free walking distance (PFWD) and stable 6-minute walking distance (6MWD). New-entry subjects showed significant improvements in both measures, while previously enrolled subjects maintained stability, alongside decreased body weight and stable blood pressure and ankle-brachial index.
Population
83 PAD patients (age 72 ± 11, 65 males) enrolled in a walking program before COVID-19 lockdown.
Effective Dosage
Two daily 8-minute sessions of slow intermittent in-home walking.
Duration
9 months pre-lockdown, with follow-up measurements 117 ± 23 days post-lockdown.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
structured in-home walking program | no change | 6-minute walking distance (6MWD) | peripheral artery disease (PAD) patients | - | was stable | #1 |
structured in-home walking program | increase | pain-free walking distance (PFWD) | peripheral artery disease (PAD) patients | - | improved | #2 |
structured in-home walking program | increase | 6-minute walking distance (6MWD) | new-entry subjects (≤ 3 months) | - | obtained significant improvements | #3 |
structured in-home walking program | increase | pain-free walking distance (PFWD) | new-entry subjects (≤ 3 months) | - | obtained significant improvements | #4 |
structured in-home walking program | no change | 6-minute walking distance (6MWD) | previously enrolled subjects (> 3 months) | - | were stable | #5 |
structured in-home walking program | no change | pain-free walking distance (PFWD) | previously enrolled subjects (> 3 months) | - | were stable | #6 |
structured in-home walking program | decrease | body weight (BW) | peripheral artery disease (PAD) patients | - | Decreased | #7 |
structured in-home walking program | no change | blood pressure (BP) | peripheral artery disease (PAD) patients | - | stable | #8 |
structured in-home walking program | no change | ankle-brachial index (ABI) | peripheral artery disease (PAD) patients | - | stable | #9 |
structured in-home walking program | neutral | program adherence | peripheral artery disease (PAD) patients | - | was adhered to by patients | #10 |
structured in-home walking program | increase | mobility | peripheral artery disease (PAD) patients | - | favored mobility | #11 |
structured in-home walking program | increase | risk factor control | peripheral artery disease (PAD) patients | - | favored risk factor control | #12 |
We studied the outcomes of peripheral artery disease (PAD) patients enrolled in a structured in-home walking program right before the lockdown due to the SARS-CoV-2 epidemic emergency, to determine whether this intervention ensured the maintenance of mobility even in the case of movement restrictions.We selectively studied 83 patients (age 72 ± 11, males n = 65) enrolled in the program within 9-month before the lockdown. The usual intervention was based on two daily 8-min sessions of slow intermittent in-home walking prescribed in circa-monthly hospital visits. During the lockdown, the program was updated by phone. Six-minute (6MWD) and pain-free walking distance (PFWD) were measured pre- and post-lockdown as well as body weight (BW), blood pressure (BP), and ankle-brachial index (ABI). Sixty-six patients were measured 117 ± 23 days after their previous visit. A safe, pain-free execution of the prescribed sessions was reported (median distance: 74 km). Overall, the 6MWD was stable, while PFWD improved (p < 0.001). The improvement was not related to age/gender, comorbidities, type of home but to the time of enrollment before lockdown. The new-entry subjects (≤ 3 months; n = 35) obtained significant improvements post-lockdown for 6MWD and PFWD, while those previously enrolled (> 3 months; n = 31) were stable. Decreased BW with stable BP and ABI values were also recorded, with better outcomes for new-entry subjects. In PAD patients, a structured walking program performed inside home and purposely guided by phone was adhered to by patients and favored mobility and risk factor control during the COVID-19 pandemic, regardless of walking ability, type of home and external conditions.